Search

Your search keyword '"Markus, Tiffanie M."' showing total 5 results
Start Over Author "Markus, Tiffanie M." Journal morbidity and mortality weekly report
5 results on '"Markus, Tiffanie M."'

1. Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults-United States, August 2022-July 2023

Author

Chard, Anna N., Dalton, Alexandra F., Diallo, Alpha Oumar, Moulia, Danielle L., Deputy, Nicholas P., Zecca, Italo B., Quilter, Laura A.S., Kachur, Rachel E., McCollum, Andrea M., Rowlands, Jemma V., Britton, Amber N., Fisher, Rebecca, Chai, Shua J., Licherdell, Erin, Still, William L., Morris, Adeline L., Castilho, Jessica L., Markus, Tiffanie M., Morrow, Allison S., Danza, Phoebe, Hansen, AmberJean P., Ali, Sophia Ibrahim, Wegner, Christopher W., Weber, Robyn, Betancourt, Gabriela S., Zipprich, Jennifer, Sutton, Melissa, Pathela, Preeti, Hawkins, Sam, Wendel, Karen A., and Feldstein, Leora R.

Subjects
Vaccination, Medical research, Medicine, Experimental, Transgender people -- Sexual behavior, Vaccines
Abstract

Introduction In May 2022, an unprecedented worldwide outbreak of clade II mpox, caused by monkeypox virus (MPXV), was detected among persons in countries with no history of sustained community transmission. [...]

Published
2024

3. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study--United States, August 19, 2022-March 31, 2023

Author

Dalton, Alexandra F., Diallo, Alpha Oumar, Chard, Anna N., Moulia, Danielle L., Deputy, Nicholas P., Fothergill, Amy, Kracalik, Ian, Wegner, Christopher W., Markus, Tiffanie M., Pathela, Preeti, Still, William L., Hawkins, Sam, Mangla, Anil T., Ravi, Nivedita, Licherdell, Erin, Britton, Amber, Lynfield, Ruth, Sutton, Melissa, Hansen, AmberJean P., Betancourt, Gabriela S., Rowlands, Jemma V., Chai, Shua J., Fisher, Rebecca, Danza, Phoebe, Farley, Monica, Zipprich, Jennifer, Prahl, Gregory, Wendel, Karen A., Niccolai, Linda, Castilho, Jessica L., Payne, Daniel C., Cohn, Amanda C., and Feldstein, Leora R.

Subjects
United States. Food and Drug Administration, Medical research, Medicine, Experimental, Transgender people, Drug approval, Vaccines, Health
Abstract

As of March 31, 2023, more than 30,000 monkeypox (mpox) cases had been reported in the United States in an outbreak that has disproportionately affected gay, bisexual, and other men [...]

Published
2023

4. Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel--33 U.S. Sites, January-March 2021

Author

Pilishvili, Tamara, Fleming-Dutra, Katherine E., Farrar, Jennifer L., Gierke, Ryan, Mohr, Nicholas M., Talan, David A., Krishnadasan, Anusha, Harland, Karisa K., Smithline, Howard A., Hou, Peter C., Lee, Lilly C., Lim, Stephen C., Moran, Gregory J., Krebs, Elizabeth, Steele, Mark, Beiser, David G., Faine, Brett, Haran, John P., Nandi, Utsav, Schrading, Walter A., Chinnock, Brian, Henning, Daniel J., LoVecchio, Frank, Nadle, Joelle, Barter, Devra, Brackney, Monica, Britton, Amber, Marceaux-Galli, Kaytlynn, Lim, Sarah, Phipps, Erin C., Dumyati, Ghinwa, Pierce, Rebecca, Markus, Tiffanie M., Anderson, Deverick J., Debes, Amanda K., Lin, Michael, Mayer, Jeanmarie, Babcock, Hilary M., Safdar, Nasia, Fischer, Marc, Singleton, Rosalyn, Chea, Nora, Magill, Shelley S., Verani, Jennifer, and Schrag, Stephanie

Subjects
Pfizer Inc., Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Vaccination -- Health aspects, Infection -- Health aspects, Medical colleges -- Health aspects, Disease transmission -- Health aspects, RNA -- Health aspects, Vaccines -- Health aspects, Medical personnel -- Health aspects, Pharmaceutical industry -- Health aspects, Health
Abstract

On May 14, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Throughout the COVID-19 pandemic, health care personnel (HCP) have been at high [...]

Published
2021

5. Symptom Profiles of a Convenience Sample of Patients with COVID-19 — United States, January–April 2020

Author

Burke, Rachel M., Killerby, Marie E., Newton, Suzanne, Ashworth, Candace E., Berns, Abby L., Brennan, Skyler, Bressler, Jonathan M., Bye, Erica, Crawford, Richard, Harduar Morano, Laurel, Lewis, Nathaniel M., Markus, Tiffanie M., Read, Jennifer S., Rissman, Tamara, Taylor, Joanne, Tate, Jacqueline E., Midgley, Claire M., Balachandran, Neha, Dahl, Rebecca M., Dott, Mary, Gilani, Zunera, Grober, Aaron, Leung, Jessica, O’Hegarty, Michelle, Person, John, Ricaldi, Jessica N., Roth, Nicole M., Sejvar, James J., Shimabukuro, Tom, Tran, Cuc H., Watson, John T., Whitham, Hilary, Chiou, Howard, Clogher, Paula, Duca, Lindsey M., Dratch, Alissa, Feldpausch, Amanda, Fill, Mary-Margaret, Ghinai, Isaac, Holshue, Michelle, Scott, Sarah, and Westergaard, Ryan

Subjects
myalgia, Male, Pediatrics, Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, 01 natural sciences, Severity of Illness Index, 0302 clinical medicine, Health Information Management, Pandemic, 030212 general & internal medicine, Full Report, Young adult, Child, Aged, 80 and over, General Medicine, Middle Aged, Hospitalization, Child, Preschool, Chills, Female, medicine.symptom, Symptom Assessment, Coronavirus Infections, Adult, medicine.medical_specialty, Adolescent, Fever, Pneumonia, Viral, MEDLINE, 03 medical and health sciences, Betacoronavirus, Young Adult, Severity of illness, medicine, Humans, 0101 mathematics, Pandemics, Aged, business.industry, SARS-CoV-2, Public health, 010102 general mathematics, COVID-19, Infant, medicine.disease, United States, Pneumonia, Dyspnea, Cough, business
Abstract

Coronavirus disease 2019 (COVID-19) was first detected in the United States in January 2020 (1), and by mid-July, approximately 3.4 million cases had been reported in the United States (2). Information about symptoms among U.S. COVID-19 patients is limited, especially among nonhospitalized patients. To better understand symptom profiles of patients with laboratory-confirmed COVID-19 in the United States, CDC used an optional questionnaire to collect detailed information on a convenience sample of COVID-19 patients from participating states. Symptom data were analyzed by age group, sex, hospitalization status, and symptom onset date relative to expansion of testing guidelines on March 8, 2020 (3). Among 164 symptomatic patients with known onset during January 14-April 4, 2020, a total of 158 (96%) reported fever, cough, or shortness of breath. Among 57 hospitalized adult patients (aged ≥18 years), 39 (68%) reported all three of these symptoms, compared with 25 (31%) of the 81 nonhospitalized adult patients. Gastrointestinal (GI) symptoms and other symptoms, such as chills, myalgia, headache, and fatigue, also were commonly reported, especially after expansion of testing guidelines. To aid prompt recognition of COVID-19, clinicians and public health professionals should be aware that COVID-19 can cause a wide variety of symptoms.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results